![]() | Klipping, C., Duijkers, I., Mawet, M., Maillard, C., Bastidas, A., Jost, M., & Foidart, J.-M. (April 2021). Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception, 103 (4), 213 - 221. doi:10.1016/j.contraception.2021.01.001 Peer Reviewed verified by ORBi |
![]() | Douxfils, J., Klipping, C., Duijkers, I., Kinet, V., Mawet, M., Maillard, C., Jost, M., Rosing, J., & Foidart, J.-M. (December 2020). Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception, 102 (6), 396 - 402. doi:10.1016/j.contraception.2020.08.015 Peer Reviewed verified by ORBi |
![]() | GASPARD, U., Taziaux, M., Mawet, M., Jost, M., Gordenne, V., Coelingh Bennink, H. J. T., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (August 2020). A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause: the Journal of the Menopause Society, 27 (8), 848-857. doi:10.1097/GME.0000000000001561 Peer Reviewed verified by ORBi |
![]() | Jost, M. (2007). Rôle des protéases et de leurs inhibiteurs au cours de processus d'angiogenèse pathologique [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315169 |